Concepedia

Mark Miglarese

MM

Statistics

Publications

13

Citations

931

H-Index

13

Active since

1994

Affiliations

University of Virginia(Current)

Center of Advanced European Studies and Research

Caris Life Sciences (United States)

University of Bonn

The University of Texas MD Anderson Cancer Center

Mark Miglarese is an author at University of Virginia specializing in oncology, molecular oncology, and life sciences.

Publications per year

1994–2020

13

Publications

13

Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak et al. · Molecular Cancer Therapeutics · 2010 · 218 citations

, , +17

Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors

Elizabeth Buck, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin et al. · Cancer Research · 2008 · 209 citations · Full text

, , +17

Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors

Beverly L. Falcón, Sharon Barr, Prafulla C. Gokhale et al. · Cancer Research · 2011 · 91 citations · Full text

, , +17

Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain.

Natasha Aziz, Mark Miglarese, Ronald C. Hendrickson et al. · Proceedings of the National Academy of Sciences · 1995 · 81 citations

, , +14

Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines

Hui Zhao, Vidhi Desai, Jian Wang et al. · Molecular Cancer Therapeutics · 2011 · 62 citations

, , +17

1–5 of 13